Insights
Insights From Our Experts
Articles
An Impactful Year for Global Regulation of Digital Health
2023 was a busy year with FDA and EU advancing key initiatives focused on AI/ML, cybersecurity, global harmonization, real-world evidence, and pharma companion apps…and more is coming in 2024. While 2023 brought its share of challenges…
Transforming Pharmaceutical Commercialization: Eight Key Insights for Success
Unlock the keys to successful pharmaceutical commercialization with our latest article: “Transforming Pharmaceutical Commercialization: Eight Key Insights for Success.” This insightful piece explores crucial, actionable strategies to transform your approach to drug launch. Here’s a glimpse…
Commercializing Digital Health as Durable Medical Equipment: A Conversation with BearingOn.Health
Posted by
Brian Abraham on December 14, 202312/14/23
Join EVERSANA’s Brian Abraham, Senior Director of Market Access and Patient Access, as he engages in a thought-provoking conversation with Adam Kaufman of BearingOn.Health. Together, they unravel the complexities surrounding digital health commercialization and reimbursement models,…
Seven Key Takeaways From a Week at AWS re:Invent 2023
AWS re:Invent 2023 was a week full of exciting announcements, inspiring keynotes, and insightful sessions impacting all industries, including healthcare and life sciences (HCLS). The event showcases the latest and greatest innovations and developments in cloud…
Linking Channel Distribution & 3PL to Non-Traditional Commercialization Touchpoints
To be competitive, maximize products and deliver exceptional customer service, trade and channel strategies must go beyond logistics. This presentation outlines how manufacturers need to connect the dots between customer type, whether they are specialty distributors,…
The Hospital of the Future and How Data, Digital and AI Merge to Make Care Better
By Pierantonio Russo, MD, FCPP, FAAP, STS, Chief Medical Officer, EVERSANA In the fast-paced realm of healthcare, innovation stands as the cornerstone of progress. Recently, I had the privilege to attend Frontier’s Health , a leading…
There’s a New Way to Omnichannel: Orchestrating Experience to Drive Sales, Savings and Satisfaction
The current state of omnichannel initiatives in the life sciences industry has often been characterized by incremental effectiveness, high costs, complexity, siloed approaches and slow progress. This is not a condemnation of the omnichannel concept, but…
Incorporating Medical Science Liaisons Early and Often Amplifies Impact and Delivers Stronger Patient Outcomes
The distinctly crucial role Medical Science Liaisons (MSLs) play in the healthcare industry helps ensure success for all stakeholders involved in a patient’s treatment journey. MSLs play a significant role in bridging the gap between scientific…
The Data-Driven Revolution: AI’s Impact on Pharmaceutical Quality in Digital Therapy
In the intricate web of pharmaceuticals, a groundbreaking transformation is underway – one that marries data analytics with digital therapy, reshaping the industry’s landscape fundamentally. As the dust settles from the FDA Symposium, a seismic shift…
Key Trends in Global Product Launch
The pharmaceutical industry continues to face a multitude of changes that have the potential to directly impact launch strategy. From more recent tangible trends like a rise in cost-containment policies, to ongoing net price transparency forces…